This Month in Psychopharmacology

THIS MONTH IN
PSYCHOPHARMACOLOGY

US Preventive Services Task Force Recommends Screening Adults for Unhealthy Drug Use
July 10, 2020

The United States Preventive Services Task Force has released updated recommendations regarding screening for unhealthy drug use in primary care settings among adults (including pregnant and postpartum women) and adolescents who...

Continue reading (Members only)

Reproducible Epigenetic Marker for Schizophrenia
July 6, 2020

A recent case-control study examined whether there is a combined contribution of methylation differences associated with Schizophrenia, similar to a polygenic risk score It also tested whether...

Interagency Autism Coordinating Committee Releases 2019 Summary of Advances in Autism Spectrum Disorder Research
July 2, 2020

In a recent study, multi-paradigm functional magnetic resonance imaging (fMRI) data from the North American Prodrome Longitudinal Study consortium was analyzed to examine differences in brain connectivity in patients who converted to schizophrenia versus those who did not. ...

Continue reading (Members only)

FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD
June 29, 2020

The US Food and Drug Administration has recently approved use of a game-based digital device for the treatment of ADHD in youths aged 8-12 years...

Consensus Statement on Use of Antipsychotic Blood Levels
June 23, 2020

It has been known that the quantification of antipsychotic levels in blood, known as therapeutic monitoring can be helpful in determining appropriate therapeutic dosing, and augmentation for treatment. It can be a useful tool for antipsychotics to manage challenging clinical scenarios, such as lack of therapeutic response, relapse, or adverse drug reactions (ADRs) related to antipsychotic treatment, especially...

Continue reading (Members only)

Effects of Yoga on Depressive Symptoms
June 19, 2020

A recent meta-analysis assessed whether physically active yoga is superior to waitlist control, treatment as usual, and attention control in alleviating depressive symptoms in individuals diagnosed with a mental disorder...

Continue reading (Members only)

FDA Approves First Drug to Image Tau Pathology in Patients Being Evaluated for Alzheimer’s Disease
June 15, 2020

The US Food and Drug Administration has approved flortaucipir F18 injection, a diagnostic agent for adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease ...

APA Condemns Racism in All Forms, Calls for End to Racial Inequalities in U.S.
June 11, 2020

In response to the institutional racism, police brutality, and killing of George Floyd brought to the forefront of national discourse, the American Psychiatric Association issued a statement that it will not stand for racism against Black Americans...

FDA Recalls Extended-Release Metformin Due to Detection of NMDA
June 5, 2020

The Food and Drug Administration has asked companies to voluntarily recall a specific type metformin over a potential cancer risk. The FDA announced that a high level of N-Nitrosodimethylamine, which is linked to cancer, was found in...

Continue reading (Members only)

Characteristics of Methamphetamine Users
June 3, 2020

The use and abuse of methamphetamine is a worldwide problem that can have very dire consequences. In this report, released by the Centers for Disease Control and Prevention and using self-reported data gathered from the 2015-2018 National Surveys on Drug Use and Health, investigators estimated methamphetamine use rates in the United States as well as ..

Top of Page